Background: A proportion of neonatal deaths from asphyxia have been shown to be associated with pre-existing brain injury.
Objectives: (a) To compare the epidemiology of infants displaying signs of birth asphyxia with those not showing signs; (b) to examine the neuropathology and determine if possible the timing of brain insult comparing asphyxiated with non-asphyxiated infants; (c) to compare the clinical features of those born with birth asphyxia with and without pre-labour damage.
Methods: Over a two year period, all 22 Scottish delivery units collected clinical details on early neonatal deaths. Requests for post mortem included separate requests for detailed neuropathological examination of the brain. Infants were classified into two groups: birth asphyxia and non-birth asphyxia. Clinicopathological correlation was used to attempt to define the time of brain insult.
Results: Detailed clinical data were available on 137 of 174 early neonatal deaths that met the inclusion criteria. Seventy of 88 parents who had agreed to post mortem examination consented to a detailed examination of additional samples from the brain; in 53 of these cases the infant was born in an asphyxiated condition. All asphyxiated and encephalopathic infants, 38% of mature and 52% of preterm infants with features of birth asphyxia but without encephalopathy, and only one of 12 infants without any signs of birth asphyxia showed damage consistent with onset before the start of labour.
Conclusions: In a large proportion of neonatal deaths, brain injury predates the onset of labour. This is more common in infants born in an asphyxiated condition.
- birth asphyxia
- cohort study
Statistics from Altmetric.com
The three major causes of neonatal death are lethal malformations, prematurity, and birth asphyxia.1 Whereas the general public considers major malformations and premature birth as unavoidable mischance, birth asphyxia implies a lack of care in labour. Although birth asphyxia is classically linked to intrapartum hypoxia-ischaemia in full term infants, often proceeding to a neonatal encephalopathy—the so-called hypoxic-ischaemic encephalopathy, a proportion of preterm babies are also born in a neurologically depressed condition almost certainly related to poor oxygenation in labour. Asphyxia is acknowledged to be an imprecise term, but is still used regularly by the profession and parents. It may be implied by one or more of the following features: a low Apgar score2–7; a baby who is difficult to resuscitate; metabolic acidosis in either the cord5,6,8,9 or early neonatal blood samples; the development of neonatal encephalopathy.10–12 A history of these particular features may be sought retrospectively if an infant goes on to develop neurodevelopmental delay. None of these indicators, when applied prospectively to infants born in poor condition, has good sensitivity, specificity, or predictive value for neurodevelopmental delay or disability, although in full term infants the development of neonatal encephalopathy is more specific.13 It is clear that perinatal asphyxia is not likely to be an important factor in the development of every case of neonatal encephalopathy or in most cases of cerebral palsy.14–19 This view has been endorsed by a statement from the International CP Task Force.20,21
Obstetric care has seen dramatic changes over the last few decades. Most changes have contributed to the steadily falling stillbirth and neonatal death rates.1,22–25 However, despite better clinical care and widespread use of fetal monitoring and fetal blood sampling, full term infants continue to be born in a neurologically depressed condition. Such infants cause considerable distress to parents and staff. They contribute both to early neonatal mortality and to the pool of children who display later neurodevelopmental disability with cerebral palsy. Although in some cases obstetric risk factors can be identified, affected children also result from pregnancies and labours that, even when scrutinised critically, appear to be normal.
Litigation for perceived perinatal mismanagement is increasingly common, particularly in relation to infants born in a neurologically depressed condition—usually manifested by a poor Apgar score—and often reflexly labelled birth asphyxia. Some recent anecdotal reports and small series of infants born in poor condition have shown neuropathological abnormality at autopsy that must have preceded the onset of labour. These generally represent the collected experience of specialist referral centres26–30 or focus on a particular age group of infants—for example, those born preterm.31–35 Only rarely do the neuropathological studies include correlation with clinical factors.36–38 Further insights into cliniconeuropathological correlation in the first weeks of life are now being achieved by neuroimaging.39 This Scottish study was set up to identify neuropathological abnormalities in a population cohort of perinatal deaths and to explore the relation between clinical features and pathological findings. We report here the findings in the neonatal deaths.
The specific aims of this paper are to:
review the epidemiology (sociodemographic, antenatal, and perinatal factors) of the early neonatal deaths overall and to compare infants who displayed signs of birth asphyxia with those who did not;
investigate the neuropathological status in those infants in whom a post mortem was authorised, and to determine whether lesions could be of prenatal origin;
determine if infants who have pre-existing brain damage are, when born alive, more likely to be born in an asphyxiated condition;
compare the antepartum and intrapartum course of early neonatal deaths of infants born with birth asphyxia with and without pre-existing damage.
Study setting and patients
The Scottish perinatal neuropathology study was a prospective observational and experimental study involving all 22 delivery units within Scotland. Patients were recruited during a two year period for each centre. The study started in January 1996, and recruitment of cases was completed by January 1999. The base study considered all perinatal deaths of infants who were ⩾ 24 weeks gestation at birth and ⩽ 7 days at time of death delivered in Scotland over the two year period. This paper concerns the epidemiology and neuropathology of the liveborn subset of the study cohort. The stillborn infants presented somewhat different features and will be reported on separately.
Infants with central nervous system or cardiac malformations, major chromosomal abnormalities, or central nervous system infection were excluded because it was felt that the neuropathological changes associated with such conditions might interfere with the interpretation of any changes superimposed by perinatal insult.
Figure 1 lists how the cohort of 692 qualifying perinatal deaths was reduced by various exclusions through the 221 liveborn infants to the 70 infants from whom the brain was available for examination in this study. These 70 infants were classified according to whether they displayed birth asphyxia (BA group) or not (noBA group). Analysis of those who died three days or less after the onset of labour allowed identification of pathological features likely to have predated labour and birth. Placentas were available for histological examination from 41 of the 70 infants.
Ethical and consent procedures
Before the start of the study, each delivery unit obtained approval from their local research ethics committee to approach appropriate parents. As different units received ethical permission at slightly varying times, the spread of data collection was three years, although it was two years for each individual centre. Cases were enrolled at the time of post mortem request by the clinician responsible for the care of the infant during life. A detailed clinical dataset was collected on all infants regardless of enrolment status. The purpose of the study was explained to parents. Signed consent was obtained for autopsy, and on a separate consent form, if authorised also for extended neuropathological research studies on the brain.
For each case a detailed questionnaire was completed by specially trained midwives or other local staff who recorded a battery of clinical information and the results of investigations relating to each pregnancy, labour, delivery, and neonatal course. This was entered into a central database (SPSS) by the study clinical coordinator (JCB). Information on the intrapartum cardiotocograph (CTG) was recorded if available.
Diagnosis of asphyxia
No test is available to accurately diagnose clinically important intrapartum asphyxia. The CTG is notorious for its poor predictive value.40,41 As one of the principle aims of the study was to determine if infants with pre-existing brain damage are predisposed to neurological depression at birth which might be labelled as birth asphyxia, we used fairly broad inclusion criteria.
An Apgar score at five minutes of ⩽ 5.0; this is the traditional assessment and it is widely recognised that a low five minute Apgar score has an association, although weak, with both neonatal death and morbidity in surviving infants.42
A cord or initial blood pH of < 7.1; obstetric epidemiology has shown that a scalp pH of less than 7.25 is abnormal and delivery is indicated if less than 7.2.40,41 The relation between scalp and cord pH is good with a sensitivity of 93%.43 However, the neonate is rarely difficult to resuscitate unless the cord pH is less than 7.0. We arbitrarily chose an intermediate level (pH < 7.1) as indicating some degree of birth asphyxia in this group of early neonatal deaths. Recognising the limitations, we also used (in the absence of a cord pH) a first blood gas with a pH less than 7.1 to indicate asphyxia.
The presence of grade 2/3 neonatal encephalopathy. This is widely accepted as having a closer association with significant birth asphyxia and long term neurodevelopmental disability.13,44 The grading of encephalopathy used was that of Sarnat and Sarnat.45
Because of the diverse clinical circumstances, not all criteria were available for assessment in each case. Infants who displayed at least one of these criteria were classified as showing clinical evidence of birth asphyxia (BA group). If none of these criteria were present, the infant was included in the non-asphyxiated group (noBA).
Autopsies were conducted in six Scottish centres, and the brain was retained in fixative for later examination. In the south east of Scotland, the fixed brains were examined in the Department of Neuropathology at the Western General Hospital, Edinburgh. Elsewhere they were sampled locally according to a previously agreed protocol. Up to 20 representative paraffin embedded blocks were prepared in each case from all areas of the cerebrum (including temporal hippocampus), and from the basal ganglia and thalami, midbrain, pons, medulla, vermis, and cerebellar hemispheres. These blocks were collected centrally for review and further investigation in Edinburgh. Paraffin sections were stained routinely with haematoxylin and eosin and luxol fast blue/cresyl violet (myelin). Selected sections were investigated immunocytochemically for astrocytic status, using an antibody to glial fibrillary acidic protein and for microglia/macrophages (antibodies to CD68 and MHCII) or stained with Perls Prussian blue stain (haemosiderin). The neuropathological appearances in grey and white matter were assessed independently in all cases by two observers (JEB and BW), who were initially blind to the clinical history. Selected cases were also reviewed by JWK. Recorded neuropathological features included neuronal eosinophilia and karyorrhexis, astrocytic hyperplasia, activated microglia and accumulation of macrophages, haemorrhage (recent and older), vascular responses, and foci of mineralisation and of infarction. The neuropathological features were then correlated with the gestational and postnatal age of the infant and with the criteria of birth asphyxia, in combination and individually.
A judgment of whether the damage dated from before the onset of labour, and was therefore prenatal, was based in part on the presence of patently mature lesions such as established infarcts, previous haemorrhage, or extensive mineralisation. However, these features were present in the minority of brain damaged infants. More diffuse features such as definite macrophage infiltration/accumulation and/or prominent reactive astrocytic hyperplasia in white matter are thought to develop over a period of more than three days (table 1). We estimated that the presence or absence of prenatal brain damage could only be determined reliably in infants who died at ⩽ 3 days of age (n = 59).
The placenta, cord, and membranes were examined macroscopically, and cord length, placental measurements, and trimmed weight were recorded. Any abnormality was described. Histological samples were taken to include a cross section of the umbilical cord, one strip of membranes (adjacent to the hole through which the baby was delivered, if identifiable), and two blocks of placenta with both fetal and maternal surfaces. Blocks and slides from the placenta and adnexa were submitted for central review in Edinburgh (JK). Histological evidence of infection, specifically chorioamnionitis in the extraplacental membranes or chorionic plate and funisitis, were recorded, as was villitis if generalised.
Data were recorded in SPSS. Descriptive statistics were used to examine the prevalence of clinical variables. The χ2 test with Yates correction (or Fisher’s exact test where sample size was less than 20) was used to compare categorical variables, and the unpaired t test or Mann-Whitney U test to compare the difference in continuous variables. Significance was assumed at p < 0.05, but we recognise that a large number of tests were performed, and some positive results at this level may have occurred by chance. As the epidemiology was performed on observational data, we leave the reader to consider the implications at this level rather than apply a correction such as that of Bonferroni. The statistical comparison of the pathology of asphyxiated and non-asphyxiated infants was made using χ2 tests with Yates’ correction.
Population and study cohort
Of the 692 deaths in the two years of the study, 221 were early neonatal deaths corresponding to the estimated early neonatal death rate of 2.5/1000 live births in Scotland.
Of the 137 deaths analysed (fig 1), 90 were classified as BA and 47 as noBA according to our liberal definition. Table 2 shows how they met the criteria for birth asphyxia. Most infants died from the effects of prematurity, congenital anomalies, or “anoxia”. The causes of death included one case each of GM1 gangliosidosis, laryngeal atresia, and diaphragmatic hernia, all of which may have contributed to the clinical picture of asphyxia. Twenty out of 137 (15%) pregnancies studied were twin (19) or triplet (one). Complications of pregnancy were common, in particular, oligohydramnios (20%), intrauterine growth restriction (14%), premature rupture of membranes (23%), and second or third trimester antepartum haemorrhage (29%). Although abnormal serum screening for α fetoprotein and human choriogonadotrophin occurred in 14 pregnancies, in only five of these was amniocentesis carried out. The other six amniocenteses were performed for amnioreduction (five) or at maternal request (one). Of 62 cases of fetal anomaly scan, 21 were abnormal (including multiple abnormalities). Two infants were conceived following induction by ovulation stimulating drugs, and two by in vitro fertilisation. Emergency caesarean section took place in 57 (42%) deliveries, of which 21 were performed before the onset of labour and 36 were intrapartum. Two infants were born by elective caesarean section, one because of a previous caesarean section and the other because it was a twin pregnancy. There was no excess over the expected proportion of early neonatal deaths delivered out of hours (2100–0900 and weekends; 61%). An abnormal infection screen was found in 15 of the total group (group B Streptococcus (seven), coliforms (four), Staphylococcus aureus (two), others (two)), of which eight were thought to have died from overwhelming sepsis (three group B Streptococcus; one group A Streptococcus; two coliforms; one Pseudomonas, and one unidentified).
Seventy neonates were fully enrolled in this study with their parents agreeing to both an autopsy and the extended brain sampling. Of these 70, 53 were thought to be asphyxiated (BA group; 23 mature (⩾ 37 weeks) and 30 preterm (24–36 weeks) infants), and 17 did not appear to be asphyxiated (noBA group; three mature (⩾ 37 weeks) and 14 preterm (24–36 weeks) infants) (fig 1). The mature infants lived for between 15 minutes and seven days, with only three surviving for more than three days. The preterm infants lived for between five minutes and 6.8 days, with only eight infants surviving for more than three days. The ratio of asphyxiated (77%) to non-asphyxiated (23%) was slightly skewed in the group of autopsied infants towards asphyxiated cases when compared with the whole cohort of liveborn infants included in the detailed epidemiological survey (n = 137; 66% asphyxiated, 34% non-asphyxiated).
Clinical comparison of BA and noBA cohorts
Detailed supplementary tables can be found at http://adc.bmjjournals.com/supplemental/. Briefly, the mothers were comparable for age, weight, height, social class, marital status, parity, and all other factors examined (supplementary table 1). Mothers of infants who were born in an asphyxiated state were less likely to have received steroids during pregnancy (20% v 36%, p = 0.036). Hyperemesis (8% v 23%, p = 0.013), placenta praevia (2% v 11%, p = 0.037), intrauterine growth retardation (10% v 23% p = 0.066), and pyrexia or flu-like illness during pregnancy (6% v 17%, p = 0.061) were less common in the BA cohort (supplementary table 2). Markers of fetal distress (supplementary table 3), such as meconium staining and cardiotocograph (CTG) abnormalities,40 were significantly more prevalent in the BA cohort (26% v 11%, p = 0.040; 59% v 33%, p = 0.004). Intrapartum infection, indicated by positive vaginal swabs, maternal pyrexia, increased white cell count, or increased C reactive protein, occurred in 12 cases (Escherichia coli and other coliforms, group B Streptococcus, and Staphylococcus aureus) but was not more common in the BA group. Malpresentation was less common in the BA cohort (30% v 45%, p = 0.087).
The noBA cohort were of younger gestation (29 v 32, p = 0.017), lighter, and had a smaller head circumference (supplementary table 4). The BA cohort, who had lower Apgar scores, required more resuscitation as a result. Eighteen (20%) infants in the BA group were asystolic at birth. Infants in the BA cohort were more likely to die early compared with those in the noBA cohort (10.3 h v 43 h, p = 0.002). Of 137 infants, only 106 were admitted to a neonatal unit. Of the remaining 31 infants, five were born in good condition and died suddenly and unexpectedly: three were found dead in their cots on the postnatal ward after transfer from the labour ward, and two suffered a sudden acute deterioration in the labour ward after a normal delivery. Twenty four infants had severe birth asphyxia, and, although they had signs of life at or shortly after birth, they could not be resuscitated sufficiently to move them to the neonatal unit. One extremely premature infant (a triplet) was given only compassionate care.
Clinical details of infants admitted to a neonatal unit were often limited because of early death (supplementary table 5). Within the first hour of birth, infants in the BA group had a considerably lower initial arterial blood pH (6.96 v 7.25, p < 0.001). In survivors of more than 12 hours, those in the BA group were more likely to have renal dysfunction (55% v 24%, p = 0.029) and to require assisted ventilation for poor respiratory drive (33% v 3%, p < 0.001). The noBA cohort, in keeping with their shorter gestation, had a greater incidence of respiratory distress syndrome and were more likely to have received exogenous surfactant (73% v 40%, p = 0.001) and to have muscular paralysis (36% v 14%, p = 0.011). In infants who survived for longer than 12 hours, abnormal neurology was documented in 83% of the BA cohort compared with 20% of the noBA cohort (p < 0.001). Seizures were significantly more common (19%) in the BA than in the no BA group (3%) (p < 0.027), but many infants (n = 30) were treated prophylactically with anticonvulsants or paralysis, and many (n = 61) died before seizures might have been expected. The groups were comparable for other features of systemic dysfunction, in particular coagulopathies, necrotising enterocolitis, cardiovascular instability, and glucose homoeostasis.
Neuropathological findings and identification of prenatal brain damage
Eighty eight infants underwent autopsy, and 70 parents authorised the additional samples required for this research study (fig 1). Table 3 shows the prevalence of neuropathological abnormalities in these 70 infants, classified into the BA and noBA groups (53 v 17) and according to their gestation (mature v preterm). Table 4 shows similar data for the infants aged 3 days and less. A detailed table of clinicopathological correlation for each infant in the group of 27 with putative prenatal brain damage has been provided for the interested reader (supplementary table 6). In table 4, the BA group has been further subdivided according to whether encephalopathy was one of the features of birth asphyxia.
In both mature and preterm infants, the asphyxiated infants were more likely to show brain damage than the non-asphyxiated, although brain damage was not universally present in asphyxiated infants (tables 3 and 4). Some infants showed evidence of continuing brain damage, with recent events such as neuronal eosinophilia and fresh haemorrhage superimposed on older lesions including established infarcts, macrophage accumulation including cells laden with haemosiderin, extensive micromineralisation, and white matter gliosis. Infants with no evidence of asphyxia at birth (mostly preterm infants) were more likely than asphyxiated infants to appear virtually normal on neuropathological examination, and such changes as were present, including haemorrhage and neuronal eosinophilia, appeared to be recent except in two mature infants who displayed prominent gliosis.
In cases in which brain damage was present, a conclusion as to whether this was likely to be of prenatal origin could be achieved only in infants who died at ⩽ 3 days of age. This was based on the presence of abnormalities thought to first appear about three days after brain injury. There is no absolute certainty about the time needed for the different responses to become visible (table 1), but the presence of accumulations of macrophages and/or prominent astrocytic hyperplasia in human white or grey matter is generally assumed to require three days or more. Evidence from the literature for this timing is presented in more detail in supplementary table 7. It is important to note that, of the 27 infants judged to have suffered prenatal brain damage, only four had survived for more than two days, six had survived one to two days, and all the rest (65%) had survived for less than one day from the onset of labour. On this basis, 26 (57%) of the asphyxiated group had evidence suggesting prenatal brain damage compared with one (8%) of the non-asphyxiated group, a highly significant difference (p < 0.005) (table 4).
Table 4 also shows that infants in the BA group who were encephalopathic displayed a particularly high prevalence of brain damage. Nine of 10 infants in this group showed macrophages or gliosis, or both, together with other confirmatory signs of continuing damage such as neuronal karyorrhexis and eosinophilia. Table 4 also highlights the fact that many of the brains of non-encephalopathic asphyxiated infants were apparently undamaged prenatally and that even by the time of death in the postnatal period, 31% of mature and 13% of preterm asphyxiated infants in this subgroup had apparently normal brains. Although the non-asphyxiated infants appeared to be more prone to postnatal or intrapartum damage, this difference was not significant (p < 0.059). Unsurprisingly, the preterm infants were more susceptible to damage of recent, and therefore probably, postnatal origin than were mature infants.
Clinical factors associated with prenatal brain damage
A careful comparison was made of the pregnancies leading to the births of infants with features of pre-labour damage (PND group, n = 27) compared with those without such damage (noPND group, n = 32). Fewer mothers in the PND group received antibiotics in pregnancy (1 v 8, p = 0.031), more had caesarean section (17 v 10, p = 0.015) and emergency caesarean section (17 v 9, p = 0.007) for CTG abnormalities (18 v 8, p = 0.005), and more had meconium present in the amniotic fluid (11 v 3, p = 0.005). The Apgar score was 0 at birth in 33% of the PND group, significantly more than in the noPND group (9 v 2, p = 0.008), and the former group were heavier and more mature (2526 v 1824 g, p = 0.033, and 34.6 v 31.2 weeks gestation, p = 0.051 respectively). The PND group were more likely to be ventilated after birth for a poor respiratory drive (8 v 3, p = 0.037), and, although both groups were acidotic, had a more acidic first pH (6.90 v 7.08, p = 0.022). The time to spontaneous respiration was longer (5 v 1 minute, p = 0.009), and the five minute Apgar score was correspondingly less good (2 v 5, p = 0.021). Reflecting the larger birth weight and more mature status, they had a higher first blood pressure (46 v 36 mm Hg, p = 0.019) and were less likely to receive surfactant (4 v 13, p = 0.024). The time to death, however, was similar in the two groups (12 v 7 hours, p = 0.42).
No differences in sociodemographic or pregnancy factors were identified between the encephalopathic and non-encephalopathic asphyxiated groups, but CTG abnormalities were present in 80% of the former group and in only 43% of the latter group (p < 0.04).
Prenatal damage and the signs of birth asphyxia
Table 5 shows the pathology of prenatal brain damage related to the criteria we used for birth asphyxia. Although the strongest clinical association with the features of pre-labour damage is the development of a neonatal encephalopathy after a low pH and a poor Apgar score at five minutes, it is of note that, of the 22 infants who had only a low Apgar score and then died and had a post mortem examination, 11 showed brain damage. By this evidence, a low Apgar score was the sole clinical indicator of prenatal damage in three of 13 mature infants and in eight of 13 preterm infants. Only 16 mature and 19 preterm infants in the PND group survived to 12 hours and remained non-paralysed; of these, 14 mature and six preterm infants had an encephalopathy. Looked at another way, 14 full term infants had clinical neonatal encephalopathy. Eight of these had a post mortem examination, and all had evidence of prenatal damage. Only six preterm infants had neonatal encephalopathy. Two of these had a post mortem, and only one had evidence of prenatal damage.
In 41 cases (59% of those who had a post mortem examination), a placenta was available for examination. In seven cases, there was histological evidence of infection, and in 33 cases there was none. All of the seven infected placentas came from infants delivered prematurely. In two (25 and 27 weeks gestation), the inflammation was focal, and in four it was more generalised (at 24, 24, 30, and 35 weeks gestation). The placenta of an additional baby, born at 41 weeks gestation, showed focal acute deciduitis without inflammation of the placenta, membranes, or cord. Only two of these infants had evidence of prenatal brain damage. Thus there was virtually no concordance of placental and brain pathology.
Early neonatal deaths
A major aim of this study was to determine the neuropathology in a geographically defined cohort of early neonatal deaths and to seek associations with events in the mother’s pregnancy, labour, and delivery, and with the infant’s condition at birth and during the period before death. We excluded infants with chromosomal abnormalities and with abnormalities of the cardiovascular and central nervous systems because these might themselves lead to neuropathological changes. We were able to review 137 cases with carefully documented clinical detail, and 70 with extensive neuropathology.
Birth asphyxia criteria
Although intrapartum hypoxia manifesting as birth asphyxia is uncommon and in decline,46 it is still viewed as a potentially preventable cause of death or damage often with expensive medicolegal implications. Yet there is much evidence that neurodevelopmental delay and cerebral palsy are associated with birth asphyxia in only a minority of cases and also that most birth asphyxiated infants do not manifest developmental delay or cerebral palsy.47,48 We used broad inclusion criteria for the diagnosis of birth asphyxia to ensure that we missed no cases and were able to evaluate the individual clinical features of asphyxia in relation to neuropathological abnormality. This may have led to the inclusion of infants whose poor condition was due to other factors such as sepsis and/or metabolic disease, including case 10 (supplementary table 6) with gangliosidosis GM1. Two thirds of our cohort of 137 infants were born in a poor condition. We used the clinical finding of depression at birth manifested by Apgar scores or fetal/neonatal acidosis as a marker of an acute intrapartum event leading to birth asphyxia. An assessment for neonatal encephalopathy in combination with these markers would have been more specific,21 but many of our infants died within hours of delivery, and a record of neurological examination was not always obtained. In addition, the administration of muscle relaxants to a fifth of our population precluded such an assessment. Finally, 70% of our group were preterm and thus unlikely to exhibit the classical signs of neonatal encephalopathy.
The epidemiological background of this cohort is similar to other recent studies from the developed world.42,49–51 Analysis of the maternal sociodemographic information and the detailed data from the pregnancy did not identify any reliable predictors for birth asphyxia or for neuropathological abnormalities. Significant placenta praevia and hyperemesis were protective against asphyxia in general, possibly because these mothers were more intensively monitored. Even taking neonatal encephalopathy in isolation as a marker for prenatal asphyxia, no differences were identified between encephalopathic and non-encephalopathic asphyxiated infants in the pregnancy or sociodemographic factors monitored in this study. A history of pyrexia or flu-like illness in pregnancy has previously been found to be associated with neonatal encephalopathy.51 Our series did not show this association, and pyrexia was more common in pregnancies that resulted in non-asphyxiated infants. Intrauterine growth restriction has previously been strongly associated with neonatal encephalopathy49,50,52 and affected 14% of our population, although not just the asphyxiated infants.
CTG abnormalities are common and are poorly predictive of fetal acidosis.53 Both CTG abnormalities and meconium staining of liquor were more common in infants with prenatal damage in this study, and CTG abnormalities proved to be the only difference between the encephalopathic BA and non-encephalopathic BA groups (80% v 43%, p < 0.04). Randomised trials have shown that, although monitoring of fetal heart rate can reduce the numbers of neonatal seizures, there is no change in the incidence of long term neurological damage,54 suggesting that some fetal heart rate abnormalities may reflect prior compromise. Although meconium staining alone has a high false positive rate,55 it is associated with increased perinatal mortality and morbidity.56 It has been hypothesised that intra-amniotic meconium may cause vasoconstriction of the umbilical vessels57 inducing fetal hypoxia-ischaemia. This is difficult to substantiate after delivery.
About half (51%) of the 137 eligible infants had detailed neuropathological investigation. The range of neuropathological abnormalities resembles those reported in previous studies,28–35,58,60,61,63–69,73 although the prevalence of neuronal damage and damage to the grey matter is higher than elsewhere. Judgments about neuropathological abnormalities are more difficult in the preterm than in the term brain. Despite these difficulties, comparison of the asphyxiated infants and those not apparently suffering from birth asphyxia shows clear differences in terms of neuropathological changes. Examination confined to infants who died within three days of the start of labour, and separation of the asphyxiated group into those with and without neonatal encephalopathy, identifies a spectrum of damage. Unsurprisingly, the mature infants who died after displaying neonatal encephalopathy are most likely to show neuropathological changes. All of the brains in this study were carefully examined to determine whether any damage could have occurred before the onset of labour. If it is accepted that features such as focal or diffuse astrocytic hyperplasia and parenchymal macrophage accumulation are cellular reactions that require three days to become established, we may conclude that most infants with features of birth asphyxia had sustained brain damage prenatally, including all eight of the full term encephalopathic group. We are unable to the establish the age of the damage, but the background of apparently normal brain development suggests that the insult was sustained not long before the start of labour. It is harder to draw conclusions about the preterm infants in this study, but the absence of neuropathological changes in virtually all the mature and most of the preterm infants who did not display asphyxia is reassuring.
We do not underestimate the difficulty of interpreting these neuropathological findings and attributing the time of onset. Every abnormality has been included in supplementary table 6, whether focal or diffuse, recent or old, but we accept that interpretation is subjective. Establishing the timing is difficult because experimental studies are not possible in human infants, although classic studies were able to relate pathology findings to major clinical incidents.60,67 Some experts also comment that the results of animal work may not be directly relevant to the human situation.60,67 Immunocytochemical investigation is mandatory to separate reactive astrocytosis from myelination gliosis. A number of the classic studies were conducted before cell specific immunocytochemistry became available, although this is not the case for more recent papers. Earlier papers may not have always included, or added, the duration of labour as a factor in timing, and interpretation may be hampered by longer survival. It is noted that the infants with a history of encephalopathy had survived for more than one day in most instances. We concede that seizure activity may induce and accelerate some of the changes seen in the brains of such infants, but the presence of diffuse astrocytosis in other infants who had survived very few hours and who died with no evidence of seizure activity reinforces the possibility of prenatal origin. A more secure evidence base for timing neuropathological events awaits the evolution of new markers of cell damage and irreversible cell death. The clinical significance of some of the lesions described such as diffuse astrocytosis, and in particular their contribution to the cause of death, remains uncertain.
Correlation of clinical factors and neuropathology
This study has failed to identify any pointers that would predict the birth of a compromised infant. Abnormal CTG, and meconium staining of liquor were the only predictive factors for birth asphyxia or prenatal brain damage. Previous studies have reported an association between oligohydramnios and prenatal brain damage possibly related to impaired blood flow in the umbilical cord. Abnormal CTG was the only clinical factor differentiating the asphyxiated infants who displayed encephalopathy and neuropathological abnormality from those who did not. Recently the presence of prenatal infection has been linked to brain damage. We found no support for this association.
Implications for surviving infants
It is possible that the neuropathological findings reported here represent the most severe end of a spectrum of perinatal brain damage resulting in a fatal outcome, while infants surviving perinatal asphyxia might show lesser degrees of similar pathology. However, the possibility also exists that dead infants and survivors represent two completely different groups in terms of both causation and pathology. Recent neuroimaging studies of surviving neonates with encephalopathy, with or without seizures, have a bearing on these questions. A large study by Cowan et al39 concluded, on the basis of magnetic resonance imaging performed in the first two weeks of life, that brain damage in mature infants with neonatal encephalopathy was most often acute and of perinatal onset particularly in an encephalopathic group without seizures. Very few infants in that study displayed evidence of prenatal brain damage on magnetic resonance imaging. Neuropathological corroboration was achieved in very few cases. In the absence of immunocytochemical investigation of gliosis and brain macrophage accumulation in all deaths, their conclusions about the prevalence of prenatal abnormalities may be an underestimate. We have discussed the difficulty of timing the lesion in our own study, in which conclusions on the presence or absence of prenatal brain damage were confined to infants who died less than three days after the onset of labour and based on neuropathological examination rather than imaging. We suggest that the cerebral insult was probably sustained only shortly before the onset of labour (even possibly precipitating the onset of labour). Evidence of continuing neuronal damage was also present in our series, not dissimilar to the findings of Cowan et al, but this was often in addition to the damage identified as occurring before labour within the constraints of current knowledge. It might be expected that brain damage in survivors would be less extensive and severe than in those with a fatal outcome. Whether the brain damage observed in our study represents the result of persisting or repeated insult, or the onset of a potentially reversible cascade accruing from a single insult, is uncertain. A multistep pathological process might present opportunities for intervention to limit further brain damage.
The fact that a significant proportion of clinically asphyxiated infants display no evidence of brain damage, and that infants who are not asphyxiated at birth often display only recent postnatal damage, offers hope for a good clinical outcome if such infants could be identified and “rescued” by medical intervention. This study shows that the current battery of investigations associated with pregnancy and labour remain blunt instruments in accurately predicting the arrival of an asphyxiated and prenatally brain damaged infant. Future work must address the development of methods for detecting antepartum damage so that optimal management of these vulnerable fetuses can be planned. Further evidence is also required on evolution of cellular reactions in the developing brain. The findings in this study support the notion that the birth of a compromised “asphyxiated” encephalopathic infant is not necessarily the result of a mismanaged labour nor the lack of vigilance in pregnancy.
This study was funded by the Scottish Home and Health Department and by Wellbeing and was dependent on the collaboration of Scottish paediatric pathologists and neuropathologists: Drs N Alsanjari, D Doyle, I Graham, E S Gray, A G Howatson, S Lang, A M Lutfy, J McCullough, J MacKenzie, K J McKenzie, J L McPhie, E R Nairn, and N M Smith. We are also grateful to the midwives and medical staff in the 22 neonatal and obstetric units throughout Scotland whose enthusiasm and help in enrolling cases and collecting data made this study possible. We are also grateful for assistance with manuscript production by Ms Angela Penman. Finally we are indebted to the families who, despite the turmoil surrounding the deaths of their infants and knowing that the results would not personally help them at their time of grief, allowed these detailed investigations to proceed.
PLease note there is an error in Table 4 (second row, last column). The correct version of table is shown below:
Pathological feature Encephalopathic
BA group (n = 10; 17%)
BA group (n = 36; 61%)
NoBA group (n = 13; 22%)
(n = 8)
(n = 2)
(n = 13)
(n = 23)
(n = 2)
(n = 11)
Neuronal eosinophilia 8 (100) 1 5 (38) 4 (17) 0 4 (36) Neuronal karyorrhexis 8 (100) 1 1 (8) 4 (17) 0 0 Grey matter infarcts 0 0 0 0 0 0 White matter gliosis* 7 (88) 1 4 (31) 9 (39) 1 0 Grey matter gliosis* 5 (63) 1 0 1 (4) 0 0 Microglial upregulation 6 (75) 1 2 (15) 9 (39) 0 1 (9) Macrophages* 7 (88) 1 1 (8) 8 (35) 0 0 Fresh haemorrhage 4 (50) 0 6 (46) 11 (48) 0 5 (45) Haemosiderin deposits 0 0 0 0 0 0 Mineral deposits 1 (13) 0 1 (8) 6 (26) 1 1 (9) *Estimated prenatal brain damage 8 (100) 1 5 (38) 12 (52) 1 0
Values in parentheses are percentages. Mature, 37 weeks; preterm, 24?36 weeks.
The tables are available as downloadable PDFs (printer friendly files).
If you do not have Adobe Reader installed on your computer,
you can download this free-of-charge, please Click here
Files in this Data Supplement:
- [View PDF] -
Table 1 Maternal sociodemographic details
Table 2 Pregnancy details
Table 3 Intrapartum details
Table 4 Infant newborn details
Table 5 Infant first week details
Table 6 Clinical & neuropathological features in neonatal deaths with putative prenatal brain damage
Table 7 Timing of CNS Injury after Cerebral Insult
- [View PDF] - Table 1 Maternal sociodemographic details
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.